Ting Liu

Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

Journal: Journal for immunotherapy of cancer

Published: May 19, 2026

Recovery of an 18th Century Rhinovirus Genome through Ancient RNA Isolation of Human Lungs.

Recovery of an 18th Century Rhinovirus Genome through Ancient RNA Isolation of Human Lungs.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

Biased continuous-time random walks with asymmetric waiting-time distributions as a model of anomalous diffusion in the presence of drift.

Biased continuous-time random walks with asymmetric waiting-time distributions as a model of anomalous diffusion in the presence of drift.

Journal: Physical review. E

Published: November 26, 2025

Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita.

Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita.

Journal: Science advances

Published: April 11, 2025

Proteomic aging signatures across mouse organs and life stages.

Proteomic aging signatures across mouse organs and life stages.

Journal: The EMBO journal

Published: March 11, 2025

Corrigendum: Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years.

Corrigendum: Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years.

Journal: Frontiers in oncology

Published: January 12, 2025

Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma.

Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma.

Journal: Experimental hematology & oncology

Published: July 11, 2024

Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine-induced killer cell efficiency in multiple myeloma via the NKG2D pathway.

Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine-induced killer cell efficiency in multiple myeloma via the NKG2D pathway.

Journal: Clinical & translational immunology

Published: February 16, 2024

Analysis of the senescence-associated cell surfaceome reveals potential senotherapeutic targets.

Analysis of the senescence-associated cell surfaceome reveals potential senotherapeutic targets.

Journal: Aging cell

Published: February 13, 2024

Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives.

Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives.

Journal: Experimental hematology & oncology

Published: January 15, 2024

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years.

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years.

Journal: Frontiers in oncology

Published: November 20, 2023

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment.

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment.

Journal: BMC medical genomics

Published: August 23, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026